Innovation

The Goliath Platform

Leading Innovation in Diagnostics Testing
WE HAVE PIONEERED ROBOTIC TESTING AND CREATED SINGLE PLATFORMS THAT TEST TENS OF THOUSANDS OF PATIENT SAMPLES IN A DAY

Fastest High-Throughput Molecular COVID-19 Detection System in the World

Pooled and Individual testing with Superior Specificity and Sensitivity

The Goliath Platforms are unique, scientifically-tested and validated instrument systems for rapid, high-throughput viral RNA detection, custom made specifically for COVID-19 testing.

Rapid high-throughput viral diagnostic
Analysis of ~400 samples for SARS-CoV-2 in under 2 hours

Most recently, we created a rapid high throughput Coronavirus detection platform in the Middle East, where processing and detection times were reduced by over 5-fold and error rates were reduced by over 85% on average.
‍
This was achieved through custom development of an automated robotic RNA extraction workstation coupled to a sensitive qRT-PCR system.

We provide rapid deployment of diagnostic testing through:

Procurement of top-line equipment from US life science equipment manufacturers

Arrangement for transport, installation, calibration, validation within 2 weeks

Training on equipment operation and interpretation of diagnostic results

Consumables purchasing with prioritization within verified supply channels

*make please these 4 paragraphs items as boxes(similar you designed for Hero)

We provide rapid deployment of diagnostic testing through:

Procurement of top-line equipment from US life science equipment manufacturers

Arrangement for transport, installation, calibration, validation within 2 weeks

Training on equipment operation and interpretation of diagnostic results

Consumables purchasing with prioritization within verified supply channels

Robotic liquid handling systems for rapid workflow

  • MINIMIZE HUMAN ERRORS
  • ACCELERATE TIME TO RESULTS
  • MINIMIZE STAFF REQUIREMENTS
The Platforms are almost completely automated, which is a distinct difference from other testing systems employed globally, operated by minimal personnel input which maximizes output, while diminishing the potential for inaccurate results due to human error.
The Goliath Platforms utilize state-of-the-art liquid handling robots manufactured in the USA.

Integrated sample controls yield validated results

By utilizing several internal nucleic acid controls through sample processing and molecular amplification, our processes are verified at each step to reduce false negatives and validate the result for each sample

Guaranteed superior quality reagent supply chain

The Platforms utilize FDA EUA-certified reagents and instruments to yield the highest accuracy within the industry, at 100% sensitivity and 100% specificity for all tests. These tests represent the “Golden Standard” for viral detection, utilizing PCR analysis of SARS-CoV-2 RNA extracted from human samples.
AccelBio has contracted with the largest US life science corporations to get significantly reduced pricing for instruments and millions of test reagents over the last few months, passing this discount down to their clients. AccelBio guarantees a continued supply of reagents and disposables for use on the Platform throughout the life of the testing capacity.

Rapid Deployment

Improved detection

AccelBio has optimized the simultaneous detection of SARS-CoV-2 and influenza

Explore Our solutions

The detection of numerous viral pathogens simultaneously will enable the rapid identification of infected individuals, accelerate their treatment, and minimize the spread of disease

COVID-19 testing:
what to know about your assays and reagents

Not All Viral Transport Media Are Made Alike: Reported Problems with Kits from China

UW Medicine halts use of coronavirus testing kits airlifted from China after some had contamination

Read more on:
The Seattle Times

CDC Highlights Updates to Collection and Handling of Clinical Specimens for COVID-19 Use and Determination

Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19

Read on:
CDC

ThermoFisher Scientific COVID-19 Combo Kit Receives Broader FDA-EUA Approval For Use in WorkFlow

FDA Further Expands EUA for Thermo Fisher Scientific's COVID-19 Diagnostic Tests

Read on:
Cision

Not All Viral Transport Media Are Made Alike: Reported Problems with Kits from China

UW Medicine halts use of coronavirus testing kits airlifted from China after some had contamination

Read more on:
The Seattle Times

CDC Highlights Updates to Collection and Handling of Clinical Specimens for COVID-19 Use and Determination

Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19

Read on:
CDC

ThermoFisher Scientific COVID-19 Combo Kit Receives Broader FDA-EUA Approval For Use in WorkFlow

FDA Further Expands EUA for Thermo Fisher Scientific's COVID-19 Diagnostic Tests

Read on:
Cision
Ask your question
Please fill out the form and we will contact you within 24 hours
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Products
Services
Customer support